[1st report on the use of an autogenous tissue adhesive in otorhinolaryngology].
An autogenous tissue glue has been developed at the ENT Department of the University Clinic Graz. It is prepared from the patient's own plasma, and has the following advantages: There is no danger of transmitting infectious diseases, there are no problems with storage, temperature and expiration date. The glue is produced at room temperature and is cheap. The production and application of this autologous tissue glue are described and a first report is given on initial experiences.
D004338:Drug Combinations / Q000302:isolation & purification / Q000627:therapeutic use; D004341:Drug Evaluation; D005176:Factor XIII / Q000302:isolation & purification / Q000627:therapeutic use; D015718:Fibrin Tissue Adhesive; D005340:Fibrinogen / Q000302:isolation & purification / Q000627:therapeutic use; D006801:Humans; D010038:Otorhinolaryngologic Diseases / Q000601:surgery*; D013917:Thrombin / Q000302:isolation & purification / Q000627:therapeutic use; D014014:Tissue Adhesives / Q000302:isolation & purification / Q000627:therapeutic use*
D004338:Drug Combinations; D015718:Fibrin Tissue Adhesive; D014014:Tissue Adhesives; D005340:Fibrinogen; D005176:Factor XIII; D013917:Thrombin
Erste Berichte über die Anwendung eines autogenen Gewebeklebers in der Hals-Nasen-Ohrenheilkunde.